Table 2 Distribution of CTD subtypes among the entire cohort, comparing patients with and without hospitalization. The table showcases the prevalence of each CTD subtype within the cohort and provides associated P-values
CTD subtype, n (%) | Entire Cohort (n = 96) | Patients with CTD associated ILD and hospitalization (n = 73) | Patients with CTD associated ILD and no hospitalization (n = 23) | P-value |
|---|---|---|---|---|
SLE | 9 (9) | 6 (8) | 3 (13) | 0.84 |
Systemic Sclerosis | 14 (15) | 11 (15) | 3 (13) | |
Idiopathic Inflammatory Myositis | 21 (22) | 16 (22) | 5 (22) | |
Sjogren Syndrome | 4 (4) | 4 (5) | 0 (0) | |
MCTD | 13 (13) | 10 (14) | 3 (13) | |
RA | 28 (29) | 22 (30) | 6 (26) | |
Overlap Syndrome | 4 (4) | 2 (3) | 2 (9) | |
Others (Spondyloarthropathies, ANCA vasculitis) | 3 (3) | 2 (3) | 1 (4) |